These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36646059)

  • 1. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
    Rao X; Jiang J; Wang Y; Ma X; Liu S
    Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of Circular RNA-Mitochondrial tRNA Translation Optimization 1 Assists the Diagnosis of High-Risk Human Papillomavirus Infection in Cervical Cancer.
    Cheng X; Shen C; Liao Z
    J Low Genit Tract Dis; 2022 Jul; 26(3):212-218. PubMed ID: 35384929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
    Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
    Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Gao F; Wang Y; Li H; Yin J
    Technol Health Care; 2024; 32(5):3083-3095. PubMed ID: 38848201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
    Cui H; Zhang B; Ruan M; Fang C; Li N; Sun X; Qi J; Zuo R; Zhang S; Rong J
    Int J Womens Health; 2022; 14():1037-1045. PubMed ID: 35966402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between serum level of miRNA-106a expression with clinicopathological characteristics and prognosis of patients with renal cell carcinoma].
    Yang Q; Liu J; Liang Y; Wang C; Han J; Zhu L; Yuan S; Sun Q; Zhang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jul; 38(7):652-655. PubMed ID: 34247370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
    Chen Y; Ma C; Zhang W; Chen Z; Ma L
    Diagn Pathol; 2014 Apr; 9():88. PubMed ID: 24774218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
    Zhang Y; Qiu S; Guo Y; Zhang J; Wu X; Hong G
    Technol Cancer Res Treat; 2021; 20():1533033821995281. PubMed ID: 33632085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
    J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
    Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
    Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of growth‑regulated oncogene‑1, hepatocyte growth factor, platelet‑derived growth factor‑AA and soluble E‑selectin and their association with high‑risk human papillomavirus infection in squamous cell carcinoma of the uterine cervix.
    Zhang Y; Wu JZ; Yang YQ; Ma R; Zhang JY; Feng JF
    Mol Med Rep; 2014 Aug; 10(2):1013-24. PubMed ID: 24889672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
    Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
    Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
    Dong A; Xu B; Wang Z; Miao X
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
    Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.